FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus
about
Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based TherapeuticsMaternal LAMP/p55gagHIV-1 DNA immunization induces in utero priming and a long-lasting immune response in vaccinated neonatesAnimal Models of Zika Virus Infection, Pathogenesis, and Immunity.Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.Maternal autism-associated IgG antibodies delay development and produce anxiety in a mouse gestational transfer modelThe expression and function of fatty acid transport protein-2 and -4 in the murine placenta.On the perplexingly low rate of transport of IgG2 across the human placenta.Neonatal Fc receptor: from immunity to therapeuticsIgG is transported across the mouse yolk sac independently of FcgammaRIIb.Abundant intracellular IgG in enterocytes and endoderm lacking FcRn.Induction of autoimmunity to brain antigens by developmental mercury exposureFc gamma receptor IIb participates in maternal IgG trafficking of human placental endothelial cells.Evidence that FcRn mediates the transplacental passage of maternal IgE in the form of IgG anti-IgE/IgE immune complexes.Relative Contribution of Dengue IgG Antibodies Acquired during Gestation or Breastfeeding in Mediating Dengue Disease Enhancement and Protection in Type I Interferon Receptor-Deficient MiceFcRn-mediated intestinal absorption of IgG anti-IgE/IgE immune complexes in mice.Maternal antibodies and developing blood-brain barrier.Antibodies and their receptors: different potential roles in mucosal defense.Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn.TNF-α and the development of the neonatal immune system: implications for inhibitor use in pregnancy.The placenta, transfer of immunoglobulins, and safety assessment of biopharmaceuticals in pregnancy.Role of IgG antibodies in association with placental function and immunologic diseases in human pregnancy.Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.The biology of the classical Fcγ receptors in non-hematopoietic cells.The multiple facets of FcRn in immunity.Gestation age dependent transfer of human immunoglobulins across placenta in timed-pregnant guinea pigs.Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice.Structural Basis of Zika Virus-Specific Antibody Protection.rEnolase maternal immunization confers caries protection on offspring.Placental transfer of Fc-containing biopharmaceuticals across species, an industry survey analysis.Preconceptual Zika virus asymptomatic infection protects against secondary prenatal infection.Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy.Distribution of FcRn Across Species and Tissues.Drug development for use during pregnancy: impact of the placenta
P2860
Q27027238-8868E224-134D-4900-800D-E6BC563103EBQ27308939-81193227-0120-4DBB-9440-FFBCE1B2936FQ30238657-D8B6A1BF-10BB-4E70-A885-A86D09B72C00Q33407495-AF843A75-D373-4A77-9958-FA9EA2D54EC2Q33897613-D1F68FC2-9B77-4C1B-8540-1ECFC6A5CAA6Q34058336-1618518E-F823-4E04-92E8-363D5CEDC7CDQ34253508-83A5AA0F-DA1E-4782-BE0B-38536CC18720Q34268801-D7C9DAA3-E119-4B23-9C1A-71B52CCFA77AQ34631875-1909D505-4D9C-4621-8311-9F7A0435E16DQ34907420-06800DFF-01F4-4881-A10A-871116C410E5Q35022574-941D9259-C918-46C7-88C8-F72216990F3CQ35234546-A9DA5C0E-0D6B-4EF3-9F4D-ADB1FFD44872Q35624937-54701A1A-980E-4262-8F37-905840247792Q36060983-0381E432-A9C7-4AFE-B295-3CFEB37DD95FQ36430141-19022FB3-56D2-4B5A-BB9F-998A881B1C45Q36556849-BC0F3F60-30AE-4ECC-A4FD-D40806C7D28FQ37015487-5700DE84-E8C2-44C8-9FB8-324653489620Q37502056-0F1D07C0-5491-4112-9915-42CF11953BD4Q37862067-B0A944F9-A498-48CB-A8FC-6B2A64D48A3EQ37986126-29A269BC-16CD-4498-B0E8-CD3A7B3CFC21Q38085053-225BAD51-966E-4D3D-9948-6864B616D9C9Q38157833-89014FB9-711D-4001-8835-D0525DC0FEFDQ38615380-D49E495E-6062-4A60-A3B9-CF14DB93BB86Q38615385-842833B9-592C-4BE1-9F95-AB08792F23CEQ38636441-824EA7B2-9DA4-4E1C-8DDF-16BD5C64712BQ40052932-BEC55672-2773-47A0-B5AF-D345F868F0B0Q40056291-63CE9D90-B6F2-4043-BEC8-27734F49820FQ43450728-E4720D03-92E0-4BF2-9AAB-02DE262A4E55Q43583667-01B7F725-99CB-4CFE-93AD-AA694A99AD40Q45324741-BCB7F43A-4FCC-4FBD-90E9-26D762AE2077Q45717061-036DC610-FA1B-467A-966B-B8549B9A619AQ46384837-4729F274-B138-418D-9887-EDC4141C1132Q58392274-9FBA4EDF-A8DB-459E-A603-39380B0A5ED6
P2860
FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus
@en
FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus.
@nl
type
label
FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus
@en
FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus.
@nl
prefLabel
FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus
@en
FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus.
@nl
P2093
P2860
P356
P1476
FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus
@en
P2093
Clark L Anderson
David Jarjoura
John M Robinson
Jonghan Kim
Keding Hua
Latha P Ganesan
Sudhasri Mohanty
William L Hayton
P2860
P304
P356
10.4049/JIMMUNOL.0803247
P407
P577
2009-03-01T00:00:00Z